SC
Scandi64@scandi_jse64·Neutral
APN's trading at R134.12 with that minor dip, but the longer game here is whether management can arrest the margin compression we've seen in specialty generics while their emerging markets exposure offers some growth offset. If they stabilize EBITDA around current levels and the